Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-13-000049

Chief Scientific Officer sold 279,300 shares at an average $0.13 ($35,820)

From the SEC's structured data for this filing

Trades in this filing

NIGALAYE ASHOK G · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2013-10-28 Sale : show line 1 in the form −139,500 $0.13 $18,065 22,316,050 I
2013-10-29 Sale : show line 2 in the form −139,800 $0.13 $17,755 22,176,250 I
Open-market sales · 279,300 sh · avg $0.13 · $35,820
Loading xslF345X03/primary_doc.xml…